3rd Quarter - Report
W STRATEGIES, LLC for ALEXION PHARMACEUTICALS
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
CMS IPPS rule as it relates to the NTAP program. Administration Executive Order on International Drug Pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.